Supreme Court Directs 19 States to Declare Cancer Notifiable Disease

• Supreme Court directs 19 states and Union territories to declare cancer a notifiable disease.
• The decision aims to establish a unified digital cancer registry to improve early detection, treatment outcomes, and overall public health.
• The court has emphasized the importance of uniform policy in addressing India's growing cancer epidemic.
• The PIL highlights major deficiencies in the National Cancer Registry Programme (NCRP), including its limited scope and lack of standardization.
• The decision is expected to bring about significant improvements in cancer surveillance, early detection, and patient care.

The absence of a unified cancer registry has led to fragmented data, poor surveillance, and a 'policy paralysis' in addressing India's growing cancer epidemic.

The Supreme Court has directed 19 states and Union territories to declare cancer a notifiable disease, paving the way for a unified digital cancer registry. This move is expected to bring about significant improvements in cancer surveillance, early detection, and patient care. The court's decision comes on the heels of a parliamentary standing committee report that recommended notifying cancer as a notifiable disease across the country. While 17 out of 36 states and UTs have already notified cancer as a notifiable disease, the Centre has been asked to issue mandatory guidelines for all states/UTs to ensure uniform policy.

The absence of a unified cancer registry has led to fragmented data, poor surveillance, and a 'policy paralysis' in addressing India's growing cancer epidemic. The National Cancer Registry Programme (NCRP), operated by the Indian Council of Medical Research (ICMR), currently covers only about 10 per cent of the country's population, with rural coverage as low as 1 per cent. This has resulted in delayed diagnosis, higher treatment costs, and poor patient outcomes.

The PIL highlights major deficiencies in the NCRP, including its limited scope and lack of standardization. The plea also points to the growing menace of unscientific and unverified alternative cancer treatments, such as the claim of Gomutra (cow urine) as a cure for cancer.

The Supreme Court's decision is based on the constitutional duty of the State under Articles 14 and 21 to provide uniform treatment to similarly-situated citizens. The court has held that the absence of mandatory reporting amounts to a grave abdication of this duty, denying citizens their fundamental right to health and a life with dignity. Both the Centre and the states hold concurrent authority to notify diseases, making it imperative for authorities to declare cancer a notifiable disease nationwide.

The PIL relies on the recommendations made in a parliamentary standing committee report, which highlighted the need for a unified cancer registry. The report noted that the current system of fragmented data collection and poor surveillance is inadequate to address India's growing cancer epidemic. By directing the Centre to issue mandatory guidelines, the court has emphasized the importance of uniform policy in addressing this public health concern.

The PIL also highlights the role of the National Cancer Registry Programme (NCRP) in collecting and analyzing cancer data. However, the NCRP's limited scope and lack of standardization have resulted in poor surveillance and a 'policy paralysis' in addressing India's growing cancer epidemic.

The Supreme Court's decision to direct 19 states and Union territories to declare cancer a notifiable disease has significant implications for patient care, data collection, and surveillance. By establishing a unified digital cancer registry, the court aims to improve early detection, treatment outcomes, and overall public health. The decision also highlights the importance of uniform policy in addressing India's growing cancer epidemic.

The PIL's emphasis on the need for a unified cancer registry has far-reaching implications for healthcare policy and practice. By prioritizing data collection, surveillance, and patient care, the court has set a precedent for addressing other public health concerns. The decision also underscores the importance of collaboration between the Centre and states in addressing complex public health issues.

The establishment of a unified digital cancer registry is expected to bring about significant improvements in cancer surveillance, early detection, and patient care. This move will not only improve treatment outcomes but also reduce healthcare costs and promote better public health.

Lawyers and compliance officers should watch for the potential implications on data collection, surveillance, and patient care in their respective jurisdictions, as well as the establishment of a unified digital cancer registry.

Source: Original reporting via Supreme Court Directs 19 States/UTs